Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.

about

Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.

Item

http://www.wikidata.org/entity/Q47755527

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@en

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@nl

type

Item

label

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@en

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@nl

prefLabel

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@en

Autoantibodies against the cal ...... ar syndromes types 2, 3 and 4.

@nl

P1476

Autoantibodies against the cal ...... lar syndromes types 2, 3 and 4

@en

P2093

Anthony P Weetman

http://www.w3.org/2001/XMLSchema#string

George J Kahaly

http://www.w3.org/2001/XMLSchema#string

Julie A Porter

http://www.w3.org/2001/XMLSchema#string

Lara Frommer

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells.

Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.

Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.

The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.

Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism.

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.13482

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Helen Kemp

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28941288

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody